NCI-N592 (Q54908213)

From Wikidata

Jump to navigation Jump to search

cell line

N592
N-592
NCI-H592
H592
H-592
NCIN592

Language	Label	Description	Also known as
English	NCI-N592	cell line	N592 N-592 NCI-H592 H592 H-592 NCIN592

Statements

1 reference

Cellosaurus release 44

23 January 2023

cancer cell line

1 reference

Cellosaurus release 44

23 January 2023

contaminated/misidentified cell line

1 reference

Cellosaurus release 44

23 January 2023

parent cell line

1 reference

Cellosaurus release 44

23 January 2023

described by source

Neuromedin B is present in lung cancer cell lines

1 reference

Cellosaurus release 44

23 January 2023

In vitro evaluation of the potential of aclarubicin in the treatment of small cell carcinoma of the lung (SCCL).

1 reference

Cellosaurus release 44

23 January 2023

Establishment and identification of small cell lung cancer cell lines having classic and variant features.

1 reference

Cellosaurus release 44

23 January 2023

NCI-Navy Medical Oncology Branch cell line data base

1 reference

Cellosaurus release 44

23 January 2023

MYC family DNA amplification in 126 tumor cell lines from patients with small cell lung cancer.

1 reference

Cellosaurus release 44

23 January 2023

Comprehensive galectin fingerprinting in a panel of 61 human tumor cell lines by RT-PCR and its implications for diagnostic and therapeutic procedures

1 reference

Cellosaurus release 44

23 January 2023

established from medical condition

lung small cell carcinoma

1 reference

Cellosaurus release 44

23 January 2023

derived from organism type

1 reference

Cellosaurus release 44

23 January 2023

Identifiers

1 reference

Cellosaurus release 44

23 January 2023

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54908213&oldid=1861576732"